Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Net Margin (2022 - 2025)

Envoy Medical's Net Margin history spans 4 years, with the latest figure at 10316.0% for Q4 2025.

  • Quarterly results put Net Margin at 10316.0% for Q4 2025, up 798400.0% from a year ago — trailing twelve months through Dec 2025 was 11892.95% (up 53950.0% YoY), and the annual figure for FY2025 was 11892.95%, up 53950.0%.
  • Net Margin for Q4 2025 was 10316.0% at Envoy Medical, up from 18445.24% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1755.0% in Q3 2023 to a low of 57385.0% in Q4 2022.
  • The 4-year median for Net Margin is 13023.91% (2024), against an average of 14710.39%.
  • The sharpest move saw Net Margin soared 5081237bps in 2023, then tumbled -1486214bps in 2024.
  • Year by year, Net Margin stood at 57385.0% in 2022, then skyrocketed by 89bps to 6572.63% in 2023, then crashed by -178bps to 18300.0% in 2024, then surged by 44bps to 10316.0% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 10316.0%, 18445.24%, and 8900.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.